EP3512552A4 - Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë - Google Patents

Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë Download PDF

Info

Publication number
EP3512552A4
EP3512552A4 EP17851497.2A EP17851497A EP3512552A4 EP 3512552 A4 EP3512552 A4 EP 3512552A4 EP 17851497 A EP17851497 A EP 17851497A EP 3512552 A4 EP3512552 A4 EP 3512552A4
Authority
EP
European Patent Office
Prior art keywords
histone
therapy
kidney injury
acute kidney
acute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17851497.2A
Other languages
German (de)
English (en)
Other versions
EP3512552A1 (fr
Inventor
Daigo NAKAZAWA
Hans-Joachim Anders
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/402,585 external-priority patent/US20170114126A1/en
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of EP3512552A1 publication Critical patent/EP3512552A1/fr
Publication of EP3512552A4 publication Critical patent/EP3512552A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP17851497.2A 2016-09-14 2017-09-14 Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë Withdrawn EP3512552A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662394529P 2016-09-14 2016-09-14
US15/402,585 US20170114126A1 (en) 2014-06-24 2017-01-10 Anti-histone therapy for vascular necrosis in severe glomerulonephritis
PCT/US2017/051485 WO2018053080A1 (fr) 2016-09-14 2017-09-14 Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë

Publications (2)

Publication Number Publication Date
EP3512552A1 EP3512552A1 (fr) 2019-07-24
EP3512552A4 true EP3512552A4 (fr) 2020-05-06

Family

ID=61619282

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17851497.2A Withdrawn EP3512552A4 (fr) 2016-09-14 2017-09-14 Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë

Country Status (3)

Country Link
EP (1) EP3512552A4 (fr)
CA (1) CA3031540A1 (fr)
WO (1) WO2018053080A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3927728A2 (fr) 2019-02-21 2021-12-29 Xencor, Inc. Protéines de fusion fc d'il-10 non ciblées et ciblées
WO2020225549A1 (fr) * 2019-05-06 2020-11-12 The Francis Crick Institute Limited Procédé de prévention de l'inflammation
CN113122538A (zh) * 2021-04-15 2021-07-16 遵义医科大学附属医院 一种靶向敲减Rip3基因表达的shRNA、重组载体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012166611A2 (fr) * 2011-05-27 2012-12-06 Immune Disease Institute, Inc. Procédés de traitement et de prévention d'une toxicité net dérivée des neutrophiles et d'une thrombose
EP3160504B1 (fr) * 2014-06-24 2020-09-16 Immunomedics, Inc. Thérapie par anti-histone pour nécrose vasculaire dans la glomérulonéphrite sévère

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Extracellular histones cause vascular necrosis in severe glomerulonephritis", 2015, UNIVERSITY MÜNCHEN, article VANKAYALA RAMAIAH ET AL: "Extracellular histones cause vascular necrosis in severe glomerulonephritis", XP055678928, DOI: https://edoc.ub.uni-muenchen.de/18767/ *
KUMAR SANTHOSH V.R. ET AL: "Neutrophil Extracellular Trap-Related Extracellular Histones Cause Vascular Necrosis in Severe GN", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 26, no. 10, 2 February 2015 (2015-02-02), US, pages 2399 - 2413, XP055926348, ISSN: 1046-6673, DOI: 10.1681/ASN.2014070673 *
See also references of WO2018053080A1 *

Also Published As

Publication number Publication date
EP3512552A1 (fr) 2019-07-24
CA3031540A1 (fr) 2018-03-22
WO2018053080A1 (fr) 2018-03-22

Similar Documents

Publication Publication Date Title
ZA201904695B (en) Amino-triazolopyridine compounds and their use in treating cancer
GB201607629D0 (en) Mutational signatures in cancer
EP3265575A4 (fr) Molécules fixant pdk20 et leurs utilisations
EP3575319A4 (fr) Molécule bifonctionnelle et son utilisation
SI3423087T1 (sl) Kombinirana terapija proti raku
EP3207162A4 (fr) Polythérapie destinée à être utilisée en cancérothérapie
IL277261A (en) Low molecular weight compounds for cancer treatment
IL258953A (en) Dihydroimidazopyrazinone derivatives are useful for the treatment of cancer
IL263123A (en) Cancer treatments
GB201511382D0 (en) Novel compounds and their use in therapy
EP3148526A4 (fr) Utilisation de l'éribuline dans le traitement du cancer
EP3419959A4 (fr) Traitement combiné
EP3367496A4 (fr) Unité de filtre et filtre
EP3266803A4 (fr) Polymère et corps réticulé associé
IL262143A (en) Improvements in cancer treatment
GB201610948D0 (en) Improvements in fencing
IL261648A (en) Cinnolin-4-amine compounds and their use in treating cancer
EP3512552A4 (fr) Thérapie anti-histone utilisée dans l'insuffisance rénale aiguë
EP3380468B8 (fr) Composés de bis-pyridazine et leur utilisation dans le traitement du cancer
EP3160504A4 (fr) Thérapie par anti-histone pour nécrose vasculaire dans la glomérulonéphrite sévère
EP3194957A4 (fr) Procédé et panel de détermination d'atteinte rénale aigüe
HK40008547A (zh) 用於癌症治疗之考比西他(cobicistat)
HK1259160A1 (en) Bis-pyridazine compounds and their use in treating cancer
HK40001222A (en) Combination therapy
AU2016905209A0 (en) Improvement in Hinges

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200402

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 259/10 20060101ALI20200328BHEP

Ipc: C07C 311/21 20060101ALI20200328BHEP

Ipc: A61K 39/395 20060101AFI20200328BHEP

Ipc: A61P 13/12 20060101ALI20200328BHEP

Ipc: C07K 16/18 20060101ALI20200328BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220603

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20221014